Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Cancer Drug Parity Act of 2019
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
Cancer Drug Parity Act (H.R. 1730/S. 741) Safe Step Act (H.R. 2279) Palliative Care Hospice Education and Training Act (H.R. 647)
Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
HR 2111/S 1048 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction (PROTECT) Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2019 · first_quarter · Q1
Funding for the National Institute of Health including the National Cancer Institute, and the Food, and Drug Administration including the Oncology Centers of Excellence and funds authorized by the Tobacco Control Act.
HR 913 - CLINICAL TREATMENT Act Implementation of the Medicare Access and CHIP Re authorization Act
Source: Senate LDA
Safe Step Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
Cancer Drug Parity Act (H.R. 1730/S. 741) Safe Step Act (H.R. 2279) Palliative Care Hospice Education and Training Act (H.R. 647)
Palliative Care and Hospice Education and Training Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
Cancer Drug Parity Act (H.R. 1730/S. 741) Safe Step Act (H.R. 2279) Palliative Care Hospice Education and Training Act (H.R. 647)
CLINICAL TREATMENT Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
HR 913 - CLINICAL TREATMENT Act Implementation of the Medicare Access and CHIP Re authorization Act
PROTECT Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
HR 2111/S 1048 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction (PROTECT) Act
Cancer Drug Parity Act of 2019
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
Cancer Drug Parity Act (H.R. 1730/S. 741) Safe Step Act (H.R. 2279) Palliative Care Hospice Education and Training Act (H.R. 647)
FDA Deeming Authority Clarification Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017 H.R. 4273/S.2100 Tobacco to 21 Act
FDA Deeming Authority Clarification Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017 H.R. 4273/S.2100 Tobacco to 21 Act
FDA Deeming Authority Clarification Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017 H.R. 4273/S.2100 Tobacco to 21 Act
FDA Deeming Authority Clarification Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017 H.R. 4273/S.2100 Tobacco to 21 Act
RACE for Children Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
RACE for Children Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
RACE for Children Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
RACE for Children Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Cancer Drug Parity Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Cancer Drug Parity Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Cancer Drug Parity Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Cancer Drug Parity Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Palliative Care and Hospice Education and Training Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Palliative Care and Hospice Education and Training Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Palliative Care and Hospice Education and Training Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Palliative Care and Hospice Education and Training Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Cancer Care Payment Reform Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1834/S. 463 - Cancer Care Payment Reform Act of 2017 Implementation of Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Implementation of Protecting Access to Medicare Act of 2014 (PAMA)
Cancer Care Payment Reform Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R. 6836, the CLINICAL TREATMENT Act H.R. 4841, the Standardizing Electronic Prior Authorization for Safe Prescribing Act H.R.1834/S. 463 - Cancer Care Payment Reform Act of 2017 Implementation of Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Implementation of Protecting Access to Medicare Act of 2014 (PAMA)
Cancer Care Payment Reform Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R. 4841, the Standardizing Electronic Prior Authorization for Safe Prescribing Act H.R.1834/S. 463 - Cancer Care Payment Reform Act of 2017 Implementation of Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Implementation of Protecting Access to Medicare Act of 2014 (PAMA)
Cancer Care Payment Reform Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R. 6836, the CLINICAL TREATMENT Act H.R. 4841, the Standardizing Electronic Prior Authorization for Safe Prescribing Act H.R.1834/S. 463 - Cancer Care Payment Reform Act of 2017 Implementation of Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Implementation of Protecting Access to Medicare Act of 2014 (PAMA)
Prescription Drug Monitoring Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Prescription Drug Monitoring Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Prescription Drug Monitoring Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Prescription Drug Monitoring Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Restoring the Patient's Voice Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Restoring the Patient's Voice Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Restoring the Patient's Voice Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Restoring the Patient's Voice Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
FDA Reauthorization Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
FDA Reauthorization Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
FDA Reauthorization Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
FDA Reauthorization Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Patient Choice and Quality Care Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Patient Choice and Quality Care Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Patient Choice and Quality Care Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Patient Choice and Quality Care Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Tobacco to 21 Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017 H.R. 4273/S.2100 Tobacco to 21 Act
Tobacco to 21 Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017 H.R. 4273/S.2100 Tobacco to 21 Act
Tobacco to 21 Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017 H.R. 4273/S.2100 Tobacco to 21 Act
Tobacco to 21 Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017 H.R. 4273/S.2100 Tobacco to 21 Act
Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R. 6836, the CLINICAL TREATMENT Act H.R. 4841, the Standardizing Electronic Prior Authorization for Safe Prescribing Act H.R.1834/S. 463 - Cancer Care Payment Reform Act of 2017 Implementation of Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Implementation of Protecting Access to Medicare Act of 2014 (PAMA)
Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R. 4841, the Standardizing Electronic Prior Authorization for Safe Prescribing Act H.R.1834/S. 463 - Cancer Care Payment Reform Act of 2017 Implementation of Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Implementation of Protecting Access to Medicare Act of 2014 (PAMA)
Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R. 6836, the CLINICAL TREATMENT Act H.R. 4841, the Standardizing Electronic Prior Authorization for Safe Prescribing Act H.R.1834/S. 463 - Cancer Care Payment Reform Act of 2017 Implementation of Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Implementation of Protecting Access to Medicare Act of 2014 (PAMA)
Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017 H.R. 4273/S.2100 Tobacco to 21 Act
Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017 H.R. 4273/S.2100 Tobacco to 21 Act
Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017 H.R. 4273/S.2100 Tobacco to 21 Act
Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017 H.R. 4273/S.2100 Tobacco to 21 Act
CLINICAL TREATMENT Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R. 6836, the CLINICAL TREATMENT Act H.R. 4841, the Standardizing Electronic Prior Authorization for Safe Prescribing Act H.R.1834/S. 463 - Cancer Care Payment Reform Act of 2017 Implementation of Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Implementation of Protecting Access to Medicare Act of 2014 (PAMA)
CLINICAL TREATMENT Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R. 6836, the CLINICAL TREATMENT Act H.R. 4841, the Standardizing Electronic Prior Authorization for Safe Prescribing Act H.R.1834/S. 463 - Cancer Care Payment Reform Act of 2017 Implementation of Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Implementation of Protecting Access to Medicare Act of 2014 (PAMA)
Childhood Cancer STAR Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Childhood Cancer STAR Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Childhood Cancer STAR Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Childhood Cancer STAR Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Right to Try Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Right to Try Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Right to Try Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Right to Try Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Tobacco to 21 Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017 H.R. 4273/S.2100 Tobacco to 21 Act
Tobacco to 21 Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017 H.R. 4273/S.2100 Tobacco to 21 Act
Tobacco to 21 Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017 H.R. 4273/S.2100 Tobacco to 21 Act
Tobacco to 21 Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017 H.R. 4273/S.2100 Tobacco to 21 Act
Childhood Cancer STAR Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Childhood Cancer STAR Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Childhood Cancer STAR Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Childhood Cancer STAR Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017 H.R. 4273/S.2100 Tobacco to 21 Act
Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017 H.R. 4273/S.2100 Tobacco to 21 Act
Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017 H.R. 4273/S.2100 Tobacco to 21 Act
Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017 H.R. 4273/S.2100 Tobacco to 21 Act
RACE for Children Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
RACE for Children Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
RACE for Children Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
RACE for Children Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Cancer Care Payment Reform Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1834/S. 463 - Cancer Care Payment Reform Act of 2017 Implementation of Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Implementation of Protecting Access to Medicare Act of 2014 (PAMA)
Cancer Care Payment Reform Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R. 6836, the CLINICAL TREATMENT Act H.R. 4841, the Standardizing Electronic Prior Authorization for Safe Prescribing Act H.R.1834/S. 463 - Cancer Care Payment Reform Act of 2017 Implementation of Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Implementation of Protecting Access to Medicare Act of 2014 (PAMA)
Cancer Care Payment Reform Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R. 6836, the CLINICAL TREATMENT Act H.R. 4841, the Standardizing Electronic Prior Authorization for Safe Prescribing Act H.R.1834/S. 463 - Cancer Care Payment Reform Act of 2017 Implementation of Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Implementation of Protecting Access to Medicare Act of 2014 (PAMA)
Cancer Care Payment Reform Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R. 4841, the Standardizing Electronic Prior Authorization for Safe Prescribing Act H.R.1834/S. 463 - Cancer Care Payment Reform Act of 2017 Implementation of Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Implementation of Protecting Access to Medicare Act of 2014 (PAMA)
Palliative Care and Hospice Education and Training Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Palliative Care and Hospice Education and Training Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Palliative Care and Hospice Education and Training Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Palliative Care and Hospice Education and Training Act
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Prescription Drug Monitoring Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Prescription Drug Monitoring Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Prescription Drug Monitoring Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Prescription Drug Monitoring Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
FDA Reauthorization Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
FDA Reauthorization Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
FDA Reauthorization Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
FDA Reauthorization Act of 2017
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
HR 2111/S 1048 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction (PROTECT) Act
Cancer Drug Parity Act (H.R. 1730/S. 741) Safe Step Act (H.R. 2279) Palliative Care Hospice Education and Training Act (H.R. 647)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2018 · fourth_quarter · Q4
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
FY 2018 and FY 2019 appropriations related to the National Institutes of Health (NIH), National Cancer Institute (NCI),Food and Drug Administration (FDA), and the Cancer Moonshot Initiative
H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017 H.R. 4273/S.2100 Tobacco to 21 Act
H.R. 6836, the CLINICAL TREATMENT Act H.R. 4841, the Standardizing Electronic Prior Authorization for Safe Prescribing Act H.R.1834/S. 463 - Cancer Care Payment Reform Act of 2017 Implementation of Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Implementation of Protecting Access to Medicare Act of 2014 (PAMA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2018 · third_quarter · Q3
FY 2018 and FY 2019 appropriations related to the National Institutes of Health (NIH), National Cancer Institute (NCI),Food and Drug Administration (FDA), and the Cancer Moonshot Initiative
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
H.R. 6836, the CLINICAL TREATMENT Act H.R. 4841, the Standardizing Electronic Prior Authorization for Safe Prescribing Act H.R.1834/S. 463 - Cancer Care Payment Reform Act of 2017 Implementation of Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Implementation of Protecting Access to Medicare Act of 2014 (PAMA)
H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017 H.R. 4273/S.2100 Tobacco to 21 Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2018 · second_quarter · Q2
H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017 H.R. 4273/S.2100 Tobacco to 21 Act
H.R. 4841, the Standardizing Electronic Prior Authorization for Safe Prescribing Act H.R.1834/S. 463 - Cancer Care Payment Reform Act of 2017 Implementation of Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Implementation of Protecting Access to Medicare Act of 2014 (PAMA)
FY 2018 and FY 2019 appropriations related to the National Institutes of Health (NIH), National Cancer Institute (NCI),Food and Drug Administration (FDA), and the Cancer Moonshot Initiative
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2018 · first_quarter · Q1
H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017 H.R. 4273/S.2100 Tobacco to 21 Act
FY 2017 and FY 2018 appropriations related to the National Institutes of Health (NIH), National Cancer Institute (NCI),Food and Drug Administration (FDA), and the Cancer Moonshot Initiative
H.R.1834/S. 463 - Cancer Care Payment Reform Act of 2017 Implementation of Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Implementation of Protecting Access to Medicare Act of 2014 (PAMA)
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act H.R. 2077 Restoring Patients Voices Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2017 · fourth_quarter · Q4
FY 2017 and FY 2018 appropriations related to the National Institutes of Health (NIH), National Cancer Institute (NCI),Food and Drug Administration (FDA), and the Cancer Moonshot Initiative
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2017 · third_quarter · Q3
FASTR Act (Free Access to Science and Technology Research Act)
H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) H.R. 1316Prescription Drug Pricing Transparency Act
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2017 · second_quarter · Q2
H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017
H.R.1834/S. 463 - Cancer Care Payment Reform Act of 2017
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) H.R. 2430 FDA Reauthorization Act S. 934 FDA Reauthorization Act H.R. 1628American Health Care Act (AHCA) H.R. 2797/ S.1334Patient Choice and Quality Care Act (PCQCA) H.R. 2999Patient's Access to Treatment Act (PATA) H.R. 1628Better Care Reconciliation Act (BCRA) HR 1703Medical ProductCommunicationsAct of 2017 H.R. 1316Prescription Drug Pricing Transparency Act
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2017 · first_quarter · Q1
H.R.1409 - Cancer Drug Parity Act of 2017 H.R.820/ S. 292 - Childhood Cancer STAR Act H.R.1231/S. 456 - RACE for Children Act H.R.1676/S. 693 - Palliative Care and Hospice Education and Training Act H.R.878 - Right to Try Act of 2017 S.204 - Trickett Wendler Right to Try Act of 2017 H.R.1854/ S. 778 - Prescription Drug Monitoring Act of 2017 Diagnostic Accuracy and Innovation Act (DAIA)(Draft legislation) FDA User Fee Reauthorization
FY 2017 and FY 2018 appropriations related to the National Institutes of Health (NIH), National Cancer Institute (NCI),Food and Drug Administration (FDA, and the Cancer Moonshot Initiative
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2016 · fourth_quarter · Q4
FY 2017 Appropriations related to the National Institutes of Health, National Cancer Institute, and Food & Drug Administration, including Continuing Resolution S 318/HR 531 Accelerating Biomedical Research Act S 289/HR 2104 American Cures Act
HR 5122, legislation to prohibit further action on the Centers for Medicare & Medicaid Services (CMS) proposed rule for the Medicare Part B Drug Demo H.R. 5001/S.2822, the Flexibility in Electronic Health Record (EHR) Reporting Act HR 1416 The Cancer Patient Protection Act of 2015 Implementation of the Medicare Access and CHIP Reauthorization Act of 2015
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2016 · third_quarter · Q3
S. 524 Comprehensive Addiction and Recovery Act of 2016 Senate HELP Committee Innovations Package HR 6 21st Century Cures Act HR 1600 Patients Access to Treatment Act of 2015 HR 2739/S 1566 Cancer Drug Coverage Parity Act HR 3381/S 1883 Childhood Cancer STAR Act HR 3119 Palliative Care Hospice Education and Training Act S 2141 Transparent Ratings on Usability and Security to Transform Information Technology (TRUST IT) Act of 2015 H.R. 2846 Planning Actively for Cancer Treatment (PACT) Act of 2015 S. 2511 Improving Health Information Technology Act Reforms to the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act
FY 2017 Appropriations related to the National Institutes of Health, National Cancer Institute, and Food & Drug Administration, including Continuing Resolution S 318/HR 531 Accelerating Biomedical Research Act S 289/HR 2104 American Cures Act
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2016 · second_quarter · Q2
FY 2017 Appropriations related to the National Institutes of Health, National Cancer Institute, and Food & Drug Administration S 318/HR 531 Accelerating Biomedical Research Act S 289/HR 2104 American Cures Act
S. 524 Comprehensive Addiction and Recovery Act of 2016 Senate HELP Committee Innovations Package HR 6 21st Century Cures Act HR 1600 Patients Access to Treatment Act of 2015 HR 2739/S 1566 Cancer Drug Coverage Parity Act HR 3381/S 1883 Childhood Cancer STAR Act HR 3119 Palliative Care Hospice Education and Training Act S 2141 Transparent Ratings on Usability and Security to Transform Information Technology (TRUST IT) Act of 2015 H.R. 2846 Planning Actively for Cancer Treatment (PACT) Act of 2015 S. 2511 Improving Health Information Technology Act Reforms to the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2016 · first_quarter · Q1
Senate HELP Committee Innovations Package HR 6 21st Century Cures Act HR 1600 Patients Access to Treatment Act of 2015 HR 2739/S 1566 Cancer Drug Coverage Parity Act HR 3381/S 1883 Childhood Cancer STAR Act HR 3119 Palliative Care Hospice Education and Training Act S 2141 Transparent Ratings on Usability and Security to Transform Information Technology (TRUST IT) Act of 2015 H.R. 2846 Planning Actively for Cancer Treatment (PACT) Act of 2015 S. 2511 Improving Health Information Technology Act S.524 Comprehensive Addiction and Recovery Act of 2016
FY 2017 Appropriations related to the National Institutes of Health, National Cancer Institute, and Food & Drug Administration S 318/HR 531 Accelerating Biomedical Research Act S 289/HR 2104 American Cures Act
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2015 · fourth_quarter · Q4
HR 2029- The Consolidated Appropriations Act of 2016 H.R.1314 - Bipartisan Budget Act of 2015 S 1695/HR 3020 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 S 1800/HR 3049 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2016 S 318/HR 531 Accelerating Biomedical Research Act S 289/HR 2104 American Cures Act HR 719 Continuing Appropriations Act, 2016
HR 1416 The Cancer Patient Protection Act of 2015
Senate HELP Committee Innovations Package HR 6 21st Century Cures Act HR 1600 Patients Access to Treatment Act of 2015 HR 2739/S 1566 Cancer Drug Coverage Parity Act HR 3381/S 1883 Childhood Cancer STAR Act HR 3119 Palliative Care Hospice Education and Training Act S 2141 Transparent Ratings on Usability and Security to Transform Information Technology (TRUST IT) Act of 2015 H.R. 2846 Planning Actively for Cancer Treatment (PACT) Act of 2015
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2015 · third_quarter · Q3
S. 779/HR 1477 FASTR Act (Free Access to Science and Technology Research Act) HR 293 To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes
HR 6 21st Century Cures Act HR 1600 Patients Access to Treatment Act of 2015 HR 2739/S 1566 Cancer Drug Coverage Parity Act HR 3381/S 1883 Childhood Cancer STAR Act HR 3119 Palliative Care Hospice Education and Training Act S 2141 Transparent Ratings on Usability and Security to Transform Information Technology (TRUST IT) Act of 2015
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2015 · second_quarter · Q2
HR 6 21st Century Cures Act HR 1600 Patients Access to Treatment Act of 2015 HR 2739/S 1566 Cancer Drug Coverage Parity Act
HR 2 The Medicare Access and CHIP Reauthorization Act HR 1416 The Cancer Patient Protection Act of 2015
S 1695/HR 3020 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 S 1800/HR 3049 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2016 S 318/HR 531 Accelerating Biomedical Research Act S 289/HR 2104 American Cures Act
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2015 · first_quarter · Q1
HR 2 The Medicare Access and CHIP Reauthorization Act
Appropriations for the National Institutes of Health (NIH), National Cancer Institute (NCI), and Food & Drug Administration (FDA) S 318/HR 531, Accelerating Biomedical Research Act S 289, American Cures Act
Draft legislation related to the House Energy & Commerce Committee's 21st Century Cures Initiative
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2014 · first_quarter · 1A
General appropriations related to the National Institutes of Health, the National Cancer Institute, and the Food and Drug Administration. HR 2019, the Gabriella Miller Kids First Research Act of 2013. S 2115 the America Cures Act. HR 4384 the America Heals Act.
HR 3033 The SOFTWARE Act
HR 4015/S 2000 SGR Repeal and Medicare Provider Payment Modernization Act of 2014
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2014 · third_quarter · 3A
HR 5214 Requires the Secretary of Health and Human Services (HHS) to consult with clinical experts and make recommendations for the use of clinical data registries to improve patient care. S 1879/HR 1801 Cancer Treatment Parity Act of 2013. HR 3033 The SOFTWARE Act.
General appropriations related to the National Institutes of Health, the National Cancer Institute, and the Food and Drug Administration. S 2115 The America Cures Act. HR 4384 the America Heals Act. S 2658/HR 5580 The Accelerating Biomedical Research Act.
HR 4015/S 2000 SGR Repeal and Medicare Provider Payment Modernization Act of 2014.
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2014 · fourth_quarter · Q4
HR 4015/S 2000 SGR Repeal and Medicare Provider Payment Modernization Act of 2014
HR 5214 Requires the Secretary of Health and Human Services (HHS) to consult with clinical experts and make recommendations for the use of clinical data registries to improve patient care. S 1879/HR 1801 Cancer Treatment Parity Act of 2013. HR 3033 The SOFTWARE Act.
General appropriations related to the National Institutes of Health, the National Cancer Institute, and the Food and Drug Administration. S 2115 the America Cures Act. HR4384 the America Heals Act. S 2658/HR 5580 the Accelerating Biomedical Research Act.
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2014 · first_quarter · 1A
HR 4015/S 2000 SGR Repeal and Medicare Provider Payment Modernization Act of 2014
HR 3033 The SOFTWARE Act
General appropriations related to the National Institutes of Health, the National Cancer Institute, and the Food and Drug Administration. HR 2019, the Gabriella Miller Kids First Research Act of 2013. S 2115 the America Cures Act. HR 4384 the America Heals Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2014 · second_quarter · Q2
General appropriations related to the National Institutes of Health, the National Cancer Institute, and the Food and Drug Administration.
The Sustainable Growth Rate, HR 4015/S 2000 SGR Repeal and Medicare Provider Payment Modernization Act; HR 1416, Cancer Patient and Protection Act of 2013
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2014 · third_quarter · Q3
HR 4015/S 2000 SGR Repeal and Medicare Provider Payment Modernization Act of 2014.
General appropriations related to the National Institutes of Health, the National Cancer Institute, and the Food and Drug Administration. S 2115 The America Cures Act. HR 4384 the America Heals Act. S 2658/HR 5580 The Accelerating Biomedical Research Act.
HR 5214 Requires the Secretary of Health and Human Services (HHS) to consult with clinical experts and make recommendations for the use of clinical data registries to improve patient care. S 1879/HR 1801 Cancer Treatment Parity Act of 2013. HR 3033 The SOFTWARE Act.
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2014 · first_quarter · Q1
The Sustainable Growth Rate, HR 4015/S 2000 SGR Repeal and Medicare Provider Payment Modernization Act; HR 1416, Cancer Patient Protection Act of 2013
HR 3033, The SOFTWARE Act; H.R.2607/S 1251, Caroline Pryce Walker Conquer Childhood Cancer Reauthorization Act; 21st Century Cures Initiative; S.Res.445 - A resolution recognizing the importance of cancer research and the contributions of scientists, clinicians, and patient advocates across the United States who are dedicated to finding a cure for cancer, and designating May 2014 as "National Cancer Research Month".
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2014 · first_quarter · Q1
HR 3033 The SOFTWARE Act.
HR 4015/S 2000 SGR Repeal and Medicare Provider Payment Modernization Act of 2014.
General appropriations related to the National Institutes of Health, the National Cancer Insitute and the Food and Drug Administration. HR 2019 the Gabriella Miller Kids First Research Act of 2013. S 2115 the America Cures Act. HR 4384 the America Heals Act.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2013 · fourth_quarter · Q4
HR 800/S 806 To amend Part B of Title XVIII of the Social Security Act to exlude customary prompt pay discounts from manufacturers to wholesalers for the average sales price for drugs and biologicals under Medicare HR 1416 Cancer Patient Protection Act of 2013; HR 2477 The Planning Actively for Cancer Treatment (PACT) Act; HR 2810 Medicare Pateint Access and Quality Improvement Act of 2013; The SGR Repeal and Medicare Beneficiary Improvement Act
HR 1801/S 1879 Cancer Drug Coverage Parity Act of 2013
General Appropriations related to the National Institutes of Health, The National Cancer Institute, and the Food and Drug Administration. HR 2019 The Kids First Research Act of 2013. Bipartisan Budget Act of 2013.
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2013 · third_quarter · Q3
HR 1801 Cancer Drug Coverage Parity Act of 2013 S 641 Palliative Care and Hospice Education Training Act S 351 Independent Payment Advisory Board (IPAB), the Protecting Seniors' Access to Medicare Act of 2013 HR 1666 Patient Centered Quality Care for Life Act
HR 800/S 806 To amend Part B of Title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare HR 1416 Cancer Patient Protection Act of 2013; HR 2477, The Planning Actively for Cancer Treatment (PACT) Act Issues related to the Sustainable Growth Rate. HR 2810 Medicare Patient Access and Quality Improvement Act of 2013
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2013 · second_quarter · Q2
General appropriations related to the National Institutes of Health, the National Cancer Institute and the Food and Drug Administration. Issues related to sequestration and the National Institutes of Health, the National Cancer Institute and the Food and Drug Administration. HR 2019 The Kids First Research Act of 2013
HR 800/S 806 To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare. HR 1416 Cancer Patient Protection Act of 2013 Medicare Physician Payment Innovation Act of 2013
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2013 · first_quarter · Q1
HR 800 - To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicas under Medicare. General issues related to the sustainable growth rate. Issues related to the application of sequestration to Part B drugs. Issues related to clinical data registries.
Issues related to cancer drug coverage parity.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2012 · fourth_quarter · Q4
HR 905 / S 733 - To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicasl under Medicare. General issues related to the sustainable growth rate. General issues related to clinical data registries participation in quality reporting for Medicare.
General appropriations related to the National Institutes of Health, the National Cancer Institute and the Food and Drug Administration. Issues related to sequestration and the National Institutes of Health, the National Cancer Institute and the Food and Drug Administration.
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2012 · third_quarter · Q3
General Appropriations related to cancer research, the National Institutes of Health, The National Cancer Institute and the Food and Drug Administration. Impact of sequestration on cancer research and oncology services under Medicare.
HR 905/733: A bill to amend Part B of Title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologics under Medicare. General issues related to the sustainable growth rate, physician payment reform and quality reporting.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2012 · second_quarter · Q2
H.R. 905/S 733. Al bill to amend Part B of Title XVIII of the SOcial Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from teh aaverage sales price for durgs and biologics under Medicare. General issues related to the sustainable growth rate, physician payment reform and ASP.
S. 296/H.R. 2245 Preserving Access to Life-Saving Medications Act Drug shortages provisions of PDUFA
General Appropriations related to cancer research, the National Institutes of Health, the National Cancer Institute and the Food and Drug Administration
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2012 · first_quarter · Q1
S 296 / HR 2245, Preserving Access to Life-Saving Medications Act
General appropriations related to cancer research, the National Institutes of Health, the National Cancer Institute, and the Food and Drug Administration
HR 905 / S 733 - To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicasl under Medicare. General issues related to the sustainable growth rate.
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2011 · fourth_quarter · Q4
H.R. 905/S 733 - To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare. Proposed cuts to Part B drugs in debt ceiling negotiations and by the Joint Select Committee on Deficit Reduction. General issues related to the sustainable growth rate (SGR).
General appropriations related to cancer research, the National Institutes of Health, the National Cancer Institute and the Food and Drug Administration
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2011 · third_quarter · Q3
HR 905 To amend Part B of Title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales proce for drugs and biologicals under Medicare; S 733 A bill to amend Part B of Title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare; General issues related to the sustainable growth rate (SGR), average sales price (ASP); General cuts to the Average Sales Price (ASP) under consideration during the debt-ceiling debate, and by the Joint Select Committee on Deficit Reduction.
General appropriations related to cancer research, the National Institutes of Health, the National Cancer Institute, and the Food and Drug Administration
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2011 · second_quarter · Q2
General appropriations related to cancer research, the National Institutes of Health, the National Cancer Institute and the Food and Drug Administration
S. 296 Preserving Access to Life-Saving Medications Act of 2011 H.R. 2245 Preserving Access to Life-Saving Medications Act of 2011
H.R. 905 To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare.; S. 733 A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare; General issues related to the sustainable growth rate and ASP.
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2011 · first_quarter · Q1
H.R. 905 - To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare. S. 733 To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare.
S. 296, Preserving Access to Life-Saving Medications Act
General appropriations related to cancer research, the National Institutes of Health, the National Cancer Institute and teh Food and Drug Administration 6th & 7th Continuing Resolution for FY 2011
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2010 · fourth_quarter · Q4
H.R. 1844, Comprehensive Cancer Care Improvement Act, seeking cosponsors
H.R. 1392 and S. 1221- an act to ensure more appropriate payment for drugs under Medicaer Part B; seeking cosponsors Medicare Reimbursement for Chemotherapy Drugs H.R. 3095, Medicare Cancer Patient Database and Coverage Act, seeking cosponsors H.R. 4994, Medicare and Medicaid Extenders Act of 2010
General Appropriations issues related to cancer research, the National Institutes of Health, the National Cancer Institute, and the Food and Drug Administration H J Res 101, 2nd Continuing Resolution; H J Res 105, 3rd Continuing Resolution; HR 3028 FY 2011 Continuing Resolution through March 4, 2011
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2010 · third_quarter · Q3
H.R. 1392 and S. 1221- an act to ensure more appropriate payment for drugs under Medicaer Part B; seeking cosponsors Medicare Reimbursement for Chemotherapy Drugs H.R. 3095, Medicare Cancer Patient Database and Coverage Act, seeking cosponsors SGR Repeal, advocacy for the repeal and temporary SGR extension (H.R. 3962, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010)
H.R. 1844, Comprehensive Cancer Care Improvement Act, seeking cosponsors
General Appropriations issues related to cancer research, the National Institutes of Health, the National Cancer Institute, and the Food and Drug Administration S. 3686 FY 2011 Labor, HHS, Education, and Related Agencies Appropriations Bill H.R. 3081 FY 2011 Continuing Resolution October 1-December 3, 2010
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2010 · second_quarter · Q2
H.R. 1392 and S. 1221- an act to ensure more appropriate payment for drugs under Medicaer Part B; seeking cosponsors Medicare Reimbursement for Chemotherapy Drugs H.R. 3095, Medicare Cancer Patient Database and Coverage Act, seeking cosponsors SGR Repeal, advocacy for the repeal and temporary SGR extensions (H.R. 4213, a bill to extend certain tax policies and stimulate job growth; H.R. 4581, the Continuing Extensions Act of 2010; and H.R. 3962, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010.)
H.R. 1844, Comprehensive Cancer Care Improvement Act, seeking cosponsors
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2010 · first_quarter · Q1
H.R. 1392 and S. 1221- an act to ensure more appropriate payment for drugs under Medicaer Part B; seeking cosponsors Medicare Reimbursement for Chemotherapy Drugs H.R. 3095, Medicare Cancer Patient Database and Coverage Act, seeking cosponsors H.R. 3961, Medicare Physician Payment Reform Act of 2009, SGR Repeal, advocacy for the repeal and temporary SGR extensions (H.R. 4213, a bill to extend certain tax policies and stimulate job growth; and H.R. 4581, the Continuing Extensions Act of 2010.)
S. 488/H.R. 716, Access to Cancer Clinical Trials Act, seeking cosponsors H.R. 1844, Comprehensive Cancer Care Improvement Act, seeking cosponsors H.R. 3590, The Patient Protection and Affordable Care Act, seeking support for the clinical trials amendment
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2009 · fourth_quarter · Q4
S. 488/H.R. 716, Access to Cancer Clinical Trials Act, seeking cosponsors H.R. 1844, Comprehensive Cancer Care Improvement Act, seeking cosponsors H.R. 3590, The Patient Protection and Affordable Care Act/H.R Affordable Health Care for America Act, seeking support for a clinical trials amendment H.R. 3590, The Patient Protection and Affordable Care Act/H.R Affordable Health Care for America Act, seeking support for a prompt pay amendment.
H.R. 3293, Labor-HHS-Education Appropriations for FY 2010 H.R. 3288, Consolidated Appropriations Act for Fy 2010 General Appropriations issues related to cancer research, the National Institutes of Health, the National Cancer Institute, and the Food and Drug Administration
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2009 · third_quarter · Q3
H.R. 1392 and S. 1221- To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program, seeking cosponsors Medicare Reimbursement for Chemotherapy Drugs H.R. 3095, Medicare Cancer Patient Database and Coverage Act, seeking cosponsors S. 1776, Medicare Physician Fairness Act of 2009/H.R. 3961, Medicare Physician Payment Reform Act of 2009, (SGR repeal) advocated for both bills
H.R. 3293, Labor-HHS-Education Appropriations for FY 2010 H.R. 3288, Consolidated Appropriations Act for Fy 2010 General Appropriations issues related to cancer research, the National Institutes of Health, the National Cancer Institute, and the Food and Drug Administration
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2009 · third_quarter · Q3
S. 488/H.R. 716, Access to Cancer Clinical Trials Act, seeking cosponsors H.R. 1844, Comprehensive Cancer Care Improvement Act, seeking cosponsors H.R.2109, Childhood Cancer Survivorship Research and Quality of Life Act, seeking cosponsors
H.R. 3293, Labor-HHS-Education Appropriations for FY 2010 H.R. 2997, Agriculture-FDA Appropriations for FY 2010 General Appropriations issues related to cancer research, the National Institutes of Health, the National Cancer Institute, and the Food and Drug Administration
H.R. 1392 and S. 1221- To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program, seeking cosponsors Medicare Reimbursement for Chemotherapy Drugs H.R. 3095, Medicare Cancer Patient Database and Coverage Act, seeking cosponsors
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2009 · second_quarter · Q2
H.R. 1392, To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program, seeking cosponsors Medicare Reimbursement for Chemotherapy Drugs H.R. 3095, Medicare Cancer Patient Database and Coverage Act, general discussions on drafting of the legislation
S. 717, 21st Century Cancer ALERT Act - discussions of draft language S. 488/H.R. 716, Access to Cancer Clinical Trials Act, seeking cosponsors, met with OPM for FEHBP coverage of clinical trials H.R. 1844, Comprehensive Cancer Care Improvement Act, discussions of draft language; seeking cosponsors H.R.2109, Childhood Cancer Survivorship Research and Quality of Life Act, discussions of draft language, seeking cosponsors
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2009 · first_quarter · Q1
H.R. 1392, To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program Medicare Reimbursement for Chemotherapy Drugs Medicare Coverage of Clinical Trials
S. 717, 21st Century Cancer ALERT Act S. 488/H.R. 716, Access to Cancer Clinical Trials Act H.R. 1548, the Pathway for Biosimilars Act H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act General discussion on draft language for childhood cancer survivorship General discussion on draft language for comprehensive care planning
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2008 · fourth_quarter · 4A
NIH/NCI Appropriations for FY 2009
Comprehensive Cancer Care Improvement Act Medicare Reimbursement for Chemotherapy Drugs Medicare Coverage of Clinical Trials
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2008 · third_quarter · 3A
NIH/NCI Appropriations for FY2009
Comprehensive Cancer Care Improviement Act - HR 1078 Medicare Reimbursement for Chemotherapy Drugs - HR 3011 Sustainable Growth Rate Medicare Coverage of Clinical Trials
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2008 · fourth_quarter · Q4
NIH/NCI Appropriations
Medicare Reimbursement of Chemotherapy Drugs Sustainable Growth Rate Comprehensive Cancer Care Improvement Act Medicare Coverage of Clinical Trials
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2008 · third_quarter · Q3
Comprehensive Cancer Care Improviement Act - HR 1078 Medicare Reimbursement for Chemotherapy Drugs - HR 3011 Sustainable Growth Rate Medicare Coverage of Clinical Trials
NIH/NCI Appropriations for FY2009
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2008 · second_quarter · Q2
NIH/NCI Approprations for FY 2009
Comprehensive Cancer Care Improvement Act - HR 1078 Medicare Reimbursement for Chemotherapy Drugs - HR 3011 Sustainable Growth Rate - HR 6331 Medicare Coverage of Clinical Trials
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2008 · first_quarter · Q1
NIH/NCI Appropriations for FY 2009
Family Smoking Prevention and Tobacco Control Act Genetic Information Nondiscrimination Act
Comprehensive Cancer Care Improvement Act - HR1078 Medicare Reimbursement for Chemotherapy Drugs - HR3011 Sustainable Growth Rate
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2007 · year_end · YY
Genetic Non-Discrimination Physician Workforce
Appropriations for National Institutes of Health Appropriations for National Cancer Institute
Medicare Reimbursement for Cancer Care Sustainable Growth Rate Medicare Coverage for Cancer Care
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2007 · mid_year · MM
Public Access Proposals Appropriations for the Nationaal Institutes of Health Appropriations for the National Cancer Institute
Tobacco Regulation
Drug Safety Biogenerics
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2006 · year_end · YY
Cancer Care Reimbursement Sustainable Growth Rate
National Institues of Health Appropriations Public Access Proposals
NIH Reauthorization Stem Cell Research
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2006 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2005 · year_end · YY
Medicare Cancer Care Demonstration Project Pay for Performance
National Institutes of Health Reauthorization Drug Safety Issues Cancer Survivorship Legislation
Public Access Proposals National Institutes of Health Appropriations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2004 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY
2004 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017 H.R. 4273/S.2100 Tobacco to 21 Act
H.R.1834/S. 463 - Cancer Care Payment Reform Act of 2017 Implementation of Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Implementation of Protecting Access to Medicare Act of 2014 (PAMA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FY 2017 and FY 2018 appropriations related to the National Institutes of Health (NIH), National Cancer Institute (NCI),Food and Drug Administration (FDA), and the Cancer Moonshot Initiative
H.R.1834/S. 463 - Cancer Care Payment Reform Act of 2017 Implementation of Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Implementation of Protecting Access to Medicare Act of 2014 (PAMA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FY 2017 and FY 2018 appropriations related to the National Institutes of Health (NIH), National Cancer Institute (NCI),Food and Drug Administration (FDA), and the Cancer Moonshot Initiative
FASTR Act (Free Access to Science and Technology Research Act)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017
H.R.1834/S. 463 - Cancer Care Payment Reform Act of 2017
FASTR Act (Free Access to Science and Technology Research Act)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S. 779/HR 1477 FASTR Act (Free Access to Science and Technology Research Act) HR 293 To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes
S. 524 Comprehensive Addiction and Recovery Act of 2016 Senate HELP Committee Innovations Package HR 6 21st Century Cures Act HR 1600 Patients Access to Treatment Act of 2015 HR 2739/S 1566 Cancer Drug Coverage Parity Act HR 3381/S 1883 Childhood Cancer STAR Act HR 3119 Palliative Care Hospice Education and Training Act S 2141 Transparent Ratings on Usability and Security to Transform Information Technology (TRUST IT) Act of 2015 H.R. 2846 Planning Actively for Cancer Treatment (PACT) Act of 2015 S. 2511 Improving Health Information Technology Act Reforms to the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S. 779/HR 1477 FASTR Act (Free Access to Science and Technology Research Act) HR 293 To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes
HR 5122, legislation to prohibit further action on the Centers for Medicare & Medicaid Services (CMS) proposed rule for the Medicare Part B Drug Demo H.R. 5001/S.2822, the Flexibility in Electronic Health Record (EHR) Reporting Act HR 1416 The Cancer Patient Protection Act of 2015 Implementation of the Medicare Access and CHIP Reauthorization Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 5122, legislation to prohibit further action on the Centers for Medicare & Medicaid Services (CMS) proposed rule for the Medicare Part B Drug Demo H.R. 5001/S.2822, the Flexibility in Electronic Health Record (EHR) Reporting Act HR 1416 The Cancer Patient Protection Act of 2015 Implementation of the Medicare Access and CHIP Reauthorization Act of 2015
S. 779/HR 1477 FASTR Act (Free Access to Science and Technology Research Act) HR 293 To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 1416 The Cancer Patient Protection Act of 2015 Implementation of the Medicare Access and CHIP Reauthorization Act of 2015
S. 779/HR 1477 FASTR Act (Free Access to Science and Technology Research Act) HR 293 To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S. 779/HR 1477 FASTR Act (Free Access to Science and Technology Research Act) HR 293 To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S 1695/HR 3020 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 S 1800/HR 3049 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2016 S 318/HR 531 Accelerating Biomedical Research Act S 289/HR 2104 American Cures Act HR 719 Continuing Appropriations Act, 2016
HR 1416 The Cancer Patient Protection Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
General appropriations for the Departments of Labor, Health and Human Services, and Education, and Related Agencies; S 2015, America Cures Act; America Heals Act, HR 4384; Gabriella Miller Kids First Research Act, HR 2019.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General appropriations related to the National Institutes of Health, the National Cancer Institute and the Food and Drug Administration. HR 2019 The Kids First Research Act of 2013; Issues related to sequestration and the National Institutes of Health, the National Cancer Institute and the Food and Drug Administration; S 1413 FDA User Fee Protection Act; HR 2725 FDA Safety Over Sequestration Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S 194 Tobacco Tax Equity Act
HR 1801 Cancer Drug Coverage Parity Act of 2013 S 641 Palliative Care and Hospice Education and Training Act S 351 Independent Payment Advisory Board (IPAB), the Protecting Seniors' Access to Medicare Act of 2013
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R. 2746, the Cancer Drug Coverage Parity Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S. 296/HR 2245, Preserving Access to Life-Saving Medications Act.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S 296 Preserving Access to Life-Saving Medications Act of 2011; HR 2245 Preserving Access to Life-Saving Medications Act of 2011
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
General Appropriations issues related to cancer research, the National Institutes of Health, the National Cancer Institute, and the Food and Drug Administration
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
General Appropriations issues related to cancer research, the National Institutes of Health, the National Cancer Institute, and the Food and Drug Administration
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
H.R. 1392 and S. 1221- To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program, seeking cosponsors Medicare Reimbursement for Chemotherapy Drugs H.R. 3095, Medicare Cancer Patient Database and Coverage Act, seeking cosponsors S. 1776, Medicare Physician Fairness Act of 2009/H.R. 3961, Medicare Physician Payment Reform Act of 2009, (SGR repeal) advocated for both bills
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
S. 488/H.R. 716, Access to Cancer Clinical Trials Act, seeking cosponsors H.R. 1844, Comprehensive Cancer Care Improvement Act, seeking cosponsors H.R. 3590, The Patient Protection and Affordable Care Act/H.R Affordable Health Care for America Act, seeking support for a clinical trials amendment H.R. 3590, The Patient Protection and Affordable Care Act/H.R Affordable Health Care for America Act, seeking support for a prompt pay amendment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
General Appropriations issues related to cancer research, the National Institutes of Health, the National Cancer Institute, and the Food and Drug Administration
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Personnel Management (OPM), SENATE
H.R. 1, The American Recovery and Reinvestment Act H.R. 1105, FY 2009 Omnibus Appropriations Act General Appropriations issues related to cancer research, the National Institutes of Health, the National Cancer Institute, and the Food and Drug Administration
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Tobacco Regulation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Medicare Reimbursement for Cancer Care Medicare Coverage for Cancer Care
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE